ADT
48
2
SIG
52
2
VTR
70
3
ZBH
45
3
KMI
65
-2
SLG
37
6
LNC
70
-2
GT
39
2
AN
52
2
UA
38
3
VNO
52
2
COP
44
-3
SPG
53
2
DUK
59
4
TGT
52
2
HSIC
62
-3
ES
50
3
STT
67
2
PX
55
2
FIS
73
11
ADT
48
2
SIG
52
2
VTR
70
3
ZBH
45
3
KMI
65
-2
SLG
37
6
LNC
70
-2
GT
39
2
AN
52
2
UA
38
3
VNO
52
2
COP
44
-3
SPG
53
2
DUK
59
4
TGT
52
2
HSIC
62
-3
ES
50
3
STT
67
2
PX
55
2
FIS
73
11
Financhill
Back

F/m US Treasury 30 Year Bond ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
47

UTHY
F/m US Treasury 30 Year Bond ETF

Last Price:
$41.74
Seasonality Move:
-5.94%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$39.6600
Seasonality Move:
33.23%
Sell
47
F/m US Treasury 30 Year Bond ETF (UTHY) is a Sell

Is F/m US Treasury 30 Year Bond ETF a Buy, Sell or Hold?

  • The current F/m US Treasury 30 Year Bond ETF [UTHY] share price is $41.74. The Score for UTHY is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • UTHY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UTHY Stock Price Chart

What is F/m US Treasury 30 Year Bond ETF's stock price today?

  • The F/m US Treasury 30 Year Bond ETF share price today is $41.74
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHY is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

UTHY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.26 Buy
Relative Strength Index (14 RSI): 48.04 Sell
Chaikin Money Flow: 1552 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.46 - 42.3) Sell
Bollinger Bands (100): (41.32 - 42.68) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

UTHY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.49 Buy
20-day SMA: 41.8 Sell
50-day SMA: 42.3 Sell
200-day SMA: 41.77 Sell
8-day EMA: 29.74 Buy
20-day EMA: 16.36 Buy
50-day EMA: 7.53 Buy
200-day EMA: 2.03 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

F/m US Treasury 30 Year Bond ETF Earnings Growth & UTHY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

F/m US Treasury 30 Year Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):